Literature DB >> 12689668

Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth.

Marlon A Guerrero1, Billy R Ballard, Ana M Grau.   

Abstract

Cystosarcoma phyllodes constitutes only 0.3-0.9% of all breast tumors. The term "sarcoma" was initially used because of its fleshy appearance, a more modern term is Phyllodes tumor (PT). The behavior of PT constitutes a spectrum from benign and locally recurrent to malignant and metastatic. In a general surgical series, 6.2% of the tumors were malignant. The microscopic appearance of PT is that of epithelial elements and connective tissue stroma. Malignancy is determined by characteristics of the stroma. The metastatic spread of malignant PT is mainly hematogenous to lung, with infrequent lymphatic involvement. Wide local excision with 2 cm margins is the treatment of choice. In 20% of both benign and malignant cases, PT will locally recur. There is no proven benefit of radiation or chemotherapy, although radiotherapy may be useful in selected cases. We present a case of a sarcomatous overgrowth in a malignant phyllodes tumor involving multiple histologic types.

Entities:  

Mesh:

Year:  2003        PMID: 12689668     DOI: 10.1016/s0960-7404(03)00005-7

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  31 in total

1.  Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.

Authors:  Benjamin Yongcheng Tan; Nur Diyana Md Nasir; Huan Ying Chang; Cedric Chuan Young Ng; Peiyong Guan; Sanjanaa Nagarajan; Vikneswari Rajasegaran; Jing Yi Lee; Jing Quan Lim; Aye Aye Thike; Bin Tean Teh; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2020-04-22       Impact factor: 7.842

2.  Diagnostic performance of core needle biopsy in identifying breast phyllodes tumors.

Authors:  Zhi-Rui Zhou; Chen-Chen Wang; Xiang-Jie Sun; Zhao-Zhi Yang; Xiao-Li Yu; Xiao-Mao Guo
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 3.  Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence.

Authors:  Zhi-Rui Zhou; Chen-Chen Wang; Zhao-Zhi Yang; Xiao-Li Yu; Xiao-Mao Guo
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.

Authors:  Valerie Cui Yun Koh; Aye Aye Thike; Nur Diyana Md Nasir; George Wai Cheong Yip; Boon Huat Bay; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

5.  Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches.

Authors:  Belén Merck; Pilar Cansado Martínez; Miguel Pérez Ramos; Natividad Martínez Banaclocha; Francisco Javier Lacueva Gómez; Rafael Calpena
Journal:  Clin Transl Oncol       Date:  2006-11       Impact factor: 3.405

6.  Advanced MRI applications and findings of malignant phyllodes tumour: review of two cases.

Authors:  Sharifah Majedah Idrus Alhabshi; Kartini Rahmat; Hasyma Abu Hassan; Caroline Judy Westerhout; Patricia Ann Chandran
Journal:  Jpn J Radiol       Date:  2013-02-06       Impact factor: 2.374

Review 7.  The Wiskott-Aldrich syndrome.

Authors:  J S Orange; K D Stone; S E Turvey; K Krzewski
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

8.  Current Trends in the Management of Phyllodes Tumors of the Breast.

Authors:  Taiwo Adesoye; Heather B Neuman; Lee G Wilke; Jessica R Schumacher; Jennifer Steiman; Caprice C Greenberg
Journal:  Ann Surg Oncol       Date:  2016-06-22       Impact factor: 5.344

9.  Long-term follow-up result of benign phyllodes tumor of the breast diagnosed and excised by ultrasound-guided vacuum-assisted breast biopsy.

Authors:  Hai-Lin Park; Sea-Hyun Kwon; So Yong Chang; Jung Yin Huh; Ji-Young Kim; Jeong Yun Shim; Yoon Hee Lee
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

10.  Lumps, bumps and GI bleeding.

Authors:  Michael Perry; Nicholas Kelly; Maurice Loughrey; Michael Hyland; Grant Caddy
Journal:  Ulster Med J       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.